pharma · T Cell Lymphoma · Diabetes Mellitus · CRSP
S.A
S.A.
S.A clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- San Lorenzo, EU
- Founded
- 2011
- Employees
- 50
- Programs
- 14
- Drugs
- 8
- Patents
- 65
S.A projects
14 ClinicalTrials.gov programs sponsored by S.A.
S.A has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CTX001
S.A.
Beta-Thalassemia
3 trials -
CTX001
S.A.
Sickle Cell Disease
2 trials -
CTX110
S.A.
B-cell Malignancy
1 trial -
CTX112
S.A.
Warm Autoimmune Hemolytic Anemia (WAIHA)
1 trial -
CTX112
S.A.
B-cell Lymphoma
1 trial -
CTX131
S.A.
Clear Cell Renal Cell Carcinoma
1 trial -
CTX131
S.A.
T Cell Lymphoma
1 trial -
CTX112
S.A.
SLE (Systemic Lupus)
1 trial -
CTX120
S.A.
Multiple Myeloma
1 trial -
CTX130
S.A.
Renal Cell Carcinoma
1 trial -
CTX130
S.A.
T Cell Lymphoma
1 trial -
CTX310
S.A.
Cardiovascular
1 trial -
VCTX210A unit
S.A.
Diabetes Mellitus
1 trial -
VCTX211
S.A.
Diabetes Mellitus
1 trial
Frequently asked questions
How many clinical projects does S.A have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.